Disseminated phaeohyphomycosis due to Ochroconis gallopavum in the setting of advanced HIV infection

References

• Hospenthal DR. Uncommon Fungi. In: Mandell G, Bennett J, Dolin R (eds). Principles and Practice of Infectious Diseases, 6th edn. Philadelphia: Churchill-Livingstone, 2005:3068–3079.
   Google Scholar
• Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992–1993: results of population-based laboratory active surveillance. Clin Infect Dis 1998; 27: 1138–1147
   PubMed Web of Science ®Google Scholar
• Revankar S, Patterson J, Sutton D, Pullen R, Rinaldi M. Disseminated phaeohyphomycosis: Review of an emerging mycosis. Clin Infect Dis 2002; 34: 467–476
   PubMed Web of Science ®Google Scholar
• Silveira F, Nucci M. Emergence of black moulds in fungal disease: epidemiology and therapy. Curr Opin Infect Dis 2001; 14: 679–684
   PubMed Web of Science ®Google Scholar
• Kralovic S, Rhodes J. Phaeohyphomycosis caused by Dactylaria (human Dactylariosis): report of a case with review of the literature. J Infect 1995; 31: 107–113
   PubMed Web of Science ®Google Scholar
• Revankar S, Sutton D, Rinaldi M. Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin Infect Dis 2004; 38: 206–216
   PubMed Web of Science ®Google Scholar
• Mancini MC, McGinnis MR. Dactylaria infections of a human being: pulmonary disease in a heart transplant recipient. J Heart Lung Transplant 1992; 11: 827–830
   PubMed Web of Science ®Google Scholar
• Prevost-Smith E (1993) , Hutton N, Padhye AA, Upshur JK, Van Bakel AB. Fatal phaeohyphomycotic infection due to Dactylaria gallopava and Scedosporium prolificans in a cardiac transplant. in: Proceedings and Abstracts of the 93rd Annual Meeting of the American Society for Microbiology, Atlanta, GA, 1993. Washington: ASM Press, : F-35.
   Google Scholar
• Vukmir RB, Kusne S, Linden P, et al. Successful therapy for cerebral phaeohyphomycosis due to Dactylaria gallopava in a liver transplant recipient. Clin Infect Dis 1994; 19: 714–719
   PubMed Web of Science ®Google Scholar
• Burns K, Ohori P, Iacono A. Dactylaria gallopava infection presenting as a pulmonary nodule in a single-lung transplant recipient. J Heart Lung Transplant 2000; 19: 900–902
   PubMed Web of Science ®Google Scholar
• Mazur J, Judson M. A case report of a Dactylaria fungal infection in a lung transplant patient. Chest 2001; 119: 651–653
   PubMed Web of Science ®Google Scholar
• Wang TK, Chiu W, Chim S, et al. Disseminated Ochroconis gallopavum infection in a renal transplant recipient: the first reported case and a review of the literature. Clin Nephrol 2003; 60: 415–423
   PubMed Web of Science ®Google Scholar
• Jenney A, Maslen M, Bergin P, et al. Pulmonary infection due to Ochroconis gallopavum treated successfully after orthotopic heart transplantation. Clin Infect Dis 1998; 26: 236–237
   PubMed Web of Science ®Google Scholar
• Fukushiro KR, Udagawa S, Kawashima Y, Kawamura Y. Subcutaneous abscesses caused by Ochroconis gallopavum. J Med Vet Mycol 1986; 24: 175–182
   PubMedGoogle Scholar
• Terreni AA, DiSalvo AF, Baker AS, et al. Disseminated Dactylaria gallopava infection in a diabetic patient with chronic lymphocytic leukemia of the T-cell type. Am J Clin Pathol 1990; 94: 104–107
   PubMed Web of Science ®Google Scholar
• Sides EH, Benson JD, Padhye AA. Phaeohyphomycotic brain abscesses due to Ochroconis gallopavum in a patient with malignant lymphoma of a large cell type. J Med Vet Mycol 1991; 29: 317–322
   PubMedGoogle Scholar
• Fukushima N, Mannen K, Okamoto S, et al. Disseminated Ochroconis gallopavum infection in a chronic lymphocytic leukemia: a case report and review of the literature on hematological malignancies. Intern Med 2005; 44: 879–882
   PubMed Web of Science ®Google Scholar
• Bowyer JD, Johnson EM, Horn EH, Gregson RM. Ochroconis gallopava endophthalmitis in fludaribine treated chronic lymphocytic leukemia. Br J Ophthalmol 2000; 84: 117–121
   PubMed Web of Science ®Google Scholar
• Zhao J, Wang Z, Li R, Wang D, Bai Y. Pemphigus patient with pulmonary fungal infection caused by Ochroconis gallopava: the first case report in China. Zhonghua Yi Xue Za Zhi 2002; 82: 1310–1313
   PubMedGoogle Scholar
• Odell J, Alvarez S, Cvitkovich D, Cortese D, McComb B. Multiple lung abscesses due to Ochroconis gallopavum, a dematiaceous fungus, in a nonimmunocompromised wood pulp worker. Chest 2000; 118: 1503–1505
   PubMed Web of Science ®Google Scholar
• Kent D, Wong T, Osgood R, et al. Fungemia due to Hormonema dematioides following intense avian exposure. Clin Infect Dis 1998; 26: 759
   PubMed Web of Science ®Google Scholar
• Marriott DJ, Wong KH, Aznar E, et al. Scytalidium dimidiatum and Lecythophora hoffmannii: unusual causes of fungal infections in a patient with AIDS. J Clin Microbiol 1997; 35: 2949–2952
   PubMed Web of Science ®Google Scholar
• Nenoff P, Gutz U, Tintelnot K, et al. Disseminated mycosis due to Scedosporium prolificans in an AIDS patient with Burkitt lymphoma. Mycoses 1996; 39: 461–465
   PubMedGoogle Scholar
• Verweij PE, Kerremans JJ, Voss A, Meis JF. Fungal contamination of tobacco and marijuana. J Am Med Assoc 2000; 284: 2875
   PubMed Web of Science ®Google Scholar
• Hamadeh R, Avdehali A, Locksley RM, York MK. Fatal aspergillosis associated with smoking contaminated marijuana in a marrow transplant recipient. Chest 1988; 94: 432–433
   PubMed Web of Science ®Google Scholar
• Marks WH, Florence L, Lieberman J, et al. Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient. Transplantation 1996; 61: 1771–1774
   PubMed Web of Science ®Google Scholar
• Szyper-Kravitz M, Lang R, Manor Y, Lehav M. Early invasive pulmonary aspergillosis in a leukemia patient linked to Aspergillus contaminated marijuana smoking. Leuk Lymph 2001; 42: 1433–1437
   PubMed Web of Science ®Google Scholar
• McGinnis MR, Pasarell L. in vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with considerations of phylogenetic implications. J Clin Microbiol 1998; 36: 2353–2355
   PubMed Web of Science ®Google Scholar
• McGinnis MR, Pasarell L, Sutton DA, et al. in vitro evaluation of voriconazole against some clinically important fungi. Antimicrob Agents Chemother 1997; 41: 1832–1834
   PubMed Web of Science ®Google Scholar
• Johnson LB, Kauffmann CA. Voriconazole: a new triazole antifungal agent. Clin Infect Dis 2003; 36: 630–637
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol 1998; 36: 2950–2956
   PubMed Web of Science ®Google Scholar
• McGinnis MR, Pasarell L. in vitro evaluation of terbinafine and itraconazole against dematiaceous fungi. Med Mycol 1998; 36: 243–246
   PubMed Web of Science ®Google Scholar
• Hay RJ. Therapeutic potential of terbinafine in subcutaneous and systemic mycoses. Br J Dermatol 1999; 141: 36–40
   PubMed Web of Science ®Google Scholar
• Perez A. Terbinafine: broad new spectrum of indications in several subcutaneous and systemic and parasitic diseases. Mycoses 1999; 42(Suppl. 2)111–114
   Google Scholar